OMKAR PHARMACHEM [OMKARPH] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

OMKAR PHARMACHEM LTD.

BSE
Loading...

Sun Pharmaceutical Industries Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: OMKAR PHARMACHEM LTD. wins in 4 metrics, Sun Pharmaceutical Industries Ltd. wins in 13 metrics, with 1 ties. Sun Pharmaceutical Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric OMKAR PHARMACHEM LTD. Sun Pharmaceutical Industries Ltd. Better
P/E Ratio (TTM) 327.78 36.73 Sun Pharmaceutical Industries Ltd.
Price-to-Book Ratio 3.13 5.15 OMKAR PHARMACHEM LTD.
Debt-to-Equity Ratio 0.00 6.68 Tie
PEG Ratio -5.03 3.59 Sun Pharmaceutical Industries Ltd.
EV/EBITDA 140.88 23.61 Sun Pharmaceutical Industries Ltd.
Profit Margin (TTM) 16.73% 19.21% Sun Pharmaceutical Industries Ltd.
Operating Margin (TTM) 37.71% 26.17% OMKAR PHARMACHEM LTD.
EBITDA Margin (TTM) 37.71% 26.17% OMKAR PHARMACHEM LTD.
Return on Equity 2.13% 15.08% Sun Pharmaceutical Industries Ltd.
Return on Assets (TTM) 2.09% 11.87% Sun Pharmaceutical Industries Ltd.
Free Cash Flow (TTM) $2.40M $119.44B Sun Pharmaceutical Industries Ltd.
Dividend Yield N/A 0.97% N/A
1-Year Return -3.09% 7.25% Sun Pharmaceutical Industries Ltd.
Price-to-Sales Ratio (TTM) 58.34 7.05 Sun Pharmaceutical Industries Ltd.
Enterprise Value $296.42M $3,783.37B Sun Pharmaceutical Industries Ltd.
EV/Revenue Ratio 58.12 6.66 Sun Pharmaceutical Industries Ltd.
Gross Profit Margin (TTM) N/A 80.96% N/A
Revenue per Share (TTM) $1 $237 Sun Pharmaceutical Industries Ltd.
Earnings per Share (Diluted) $0.09 $45.46 Sun Pharmaceutical Industries Ltd.
Beta (Stock Volatility) 0.10 0.11 OMKAR PHARMACHEM LTD.

OMKAR PHARMACHEM LTD. vs Sun Pharmaceutical Industries Ltd. Stock Performance Analysis

Loading Price Chart...

OMKARPH
SUNPHARMA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
OMKAR PHARMACHEM LTD.-4.99%-5.00%-8.49%-13.05%-9.46%-13.75%
Sun Pharmaceutical Industries Ltd.-0.08%-2.77%-1.84%2.13%-0.53%4.00%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
OMKAR PHARMACHEM LTD.-3.09%8.00%35.68%344.81%413.31%581.82%
Sun Pharmaceutical Industries Ltd.7.25%79.99%166.96%144.01%669.48%2,278.32%

Performance & Financial Health Analysis: OMKAR PHARMACHEM LTD. vs Sun Pharmaceutical Industries Ltd.

MetricOMKARPHSUNPHARMA
Market Information
Market Cap i₹297.55M₹3.88T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i43,903,142
90 Day Avg. Volume i13,253,866
Last Close₹24.37₹1,788.50
52 Week Range₹24.37 - ₹29.74₹1,548.00 - ₹1,916.60
% from 52W High-18.06%-6.68%
All-Time High₹30.09 (May 26, 2025)₹1,960.35 (Sep 30, 2024)
% from All-Time High-19.01%-8.77%
Growth Metrics
Quarterly Revenue Growth-0.22%0.14%
Quarterly Earnings Growth-0.65%0.16%
Financial Health
Profit Margin (TTM) i0.17%0.19%
Operating Margin (TTM) i0.38%0.26%
Return on Equity (TTM) i0.02%0.15%
Debt to Equity (MRQ) i0.006.68
Cash & Liquidity
Book Value per Share (MRQ)₹9.44₹324.46
Cash per Share (MRQ)₹0.06₹115.87
Operating Cash Flow (TTM) i₹2.44M₹110.84B
Levered Free Cash Flow (TTM) i₹2.01M₹109.29B
Dividends
Last 12-Month Dividend Yield iN/A0.97%
Last 12-Month Dividend iN/A₹16.50

Valuation & Enterprise Metrics Analysis: OMKAR PHARMACHEM LTD. vs Sun Pharmaceutical Industries Ltd.

MetricOMKARPH (Apr 24, 2026)SUNPHARMA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i327.7836.73
Forward P/E iN/A29.48
PEG Ratio i-5.033.59
Price to Sales (TTM) i58.347.05
Price to Book (MRQ) i3.135.15
Market Capitalization
Market Capitalization i₹297.55M₹3.88T
Enterprise Value i₹296.42M₹3.78T
Enterprise Value Metrics
Enterprise to Revenue i58.126.66
Enterprise to EBITDA i140.8823.61
Risk & Other Metrics
Beta i0.100.11
Book Value per Share (MRQ) i₹9.44₹324.46

Financial Statements Comparison: OMKAR PHARMACHEM LTD. vs Sun Pharmaceutical Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricOMKARPH (2025)SUNPHARMA (2025)
Revenue/Sales i5.40M520.41B
Cost of Goods Sold i0121.98B
COGS % of Revenue i0.0%23.4%
Gross Profit i5.40M398.44B
Gross Margin i100.0%76.6%
Research & Development iN/AN/A
Operating Income (EBIT) i2.86M125.81B
Operating Margin i53.0%24.2%
EBITDA i2.93M167.25B
EBITDA Margin i54.3%32.1%
Pre-Tax Income i2.70M137.52B
Pre-Tax Income % of Revenue i50.0%26.4%
Income Tax i691,00027.72B
Income Tax % of Revenue i12.8%5.3%
Net Income (Profit) i2.01M109.65B
Profit Margin i37.2%21.1%

Balance Sheet & Liquidity Metrics

MetricOMKARPH (2025)SUNPHARMA (2025)
Cash & Equivalents i1.09M102.69B
Total Current Assets i2.65M526.24B
Total Current Assets % of Revenue i49.1%101.1%
Total Current Liabilities i1.70M181.94B
Total Current Liabilities % of Revenue i31.4%35.0%
Long-Term Debt i03.58B
Long-Term Debt % of Revenue i0.0%0.7%
Total Shareholders Equity i94.34M724.86B
Retained Earnings i-6.50M578.62B
Retained Earnings % of Revenue i-120.4%111.2%
Property, Plant & Equipment i183,000100.36B

Cash Flow Statement Comparison

MetricOMKARPH (2025)SUNPHARMA (2025)
Operating Cash Flow i2.44M110.84B
Operating Cash Flow % of Revenue i45.2%21.3%
Capital Expenditures i-40,000-20.68B
Free Cash Flow i2.40M119.44B
FCF Margin i44.4%23.0%
Debt Repayment iN/A-43.44B
Common Stock Repurchase iN/A-29.00B

Short Interest & Institutional Ownership Analysis

MetricOMKARPHSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i10.08M2.40B
Float Shares i4.97M1.07B
% Held by Insiders i51.14%55.62%
% Held by Institutions i0.00%28.69%
% Held by Public i48.86%15.69%

Dividend Analysis & Yield Comparison: OMKAR PHARMACHEM LTD. vs Sun Pharmaceutical Industries Ltd.

MetricOMKARPHSUNPHARMA
Last 12-Month Dividend iN/A₹16.50
Last 12-Month Dividend Yield iN/A0.97%
3-Year Avg Annual Dividend iN/A₹17.33
3-Year Avg Dividend Yield iN/A0.51%
3-Year Total Dividends iN/A₹52.00
Ex-Dividend DateN/AFeb 05, 2026